Pancella is Biotechnology in Canada that focus on healthcare industry business. Founded in 2017. They cover business area such as developer, medicinal cell therapy, degenerative and malignant disease, absolute control, deregulated cell proliferation, a tight link, a drug inducible suicide gene, a gene, cell division, clinician, potentially malignant cell, transplantation.
2017
( 7 years old in 2024 )
Healthcare Industry
-
MaRS Centre, West Tower
661 University Avenue, Suite 1300
Toronto, Ontario M5G 0B7
Canada
Private
developermedicinal cell therapydegenerative and malignant diseaseabsolute controlderegulated cell proliferationa tight linka drug inducible suicide genea genecell divisionclinicianpotentially malignant celltransplantation
* We use standard office opening hours in near Pancella's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Pancella is Biotechnology business from Canada that founded in 2017 (7 years old in 2024), Pancella business is focusing on Healthcare Industry.
Pancella headquarter office and corporate office address is located in MaRS Centre, West Tower 661 University Avenue, Suite 1300 Toronto, Ontario M5G 0B7 Canada.
Pancella was founded in Canada.
In 2024, Pancella is currently focus on healthcare industry sector.
Above is snippet of Google Trends for "healthcare industry" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Pancella, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
